You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zolinza (vorinostat)

Showing 1 - 25 of 194
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

Recruiting
  • Ewing Sarcoma
  • +5 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +4 more
Feb 1, 2023

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Nov 1, 2021

CNS Tumors Trial in Saint Petersburg (25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®), 50 mg/m2

Terminated
Has Results
  • Central Nervous System Tumors
  • 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
  • +4 more
  • Saint Petersburg, Florida
    Johns Hopkins All Childen's Hospital
Mar 8, 2021

Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)

Active, not recruiting
  • Squamous Cell Lung Cancer
  • +5 more
  • pembrolizumab; vorinostat
  • Angers, France
  • +13 more
Jan 4, 2023

HIV Trial in Melbourne (Disulfiram, (National Drug Code) NDC 0378-4141-01, Vorinostat, NDC 00006-0568-40)

Terminated
  • HIV Infections
  • Disulfiram, (National Drug Code) NDC 0378-4141-01
  • Vorinostat, NDC 00006-0568-40
  • Melbourne, Victoria, Australia
    Department of Infectious Diseases, Alfred Hospital
Oct 27, 2021

Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
  • Hackensack, New Jersey
    Hackensack University Medical Center
Oct 4, 2021

HIV-1 Infection Trial in Chapel Hill (VRC07-523LS, Vorinostat (VOR))

Completed
Has Results
  • HIV-1 Infection
  • VRC07-523LS
  • Vorinostat (VOR)
  • Chapel Hill, North Carolina
    University of North Carolina Health Care
Nov 4, 2021

Multiple Myeloma Trial (Vorinostat, bortezomib, to vorinostat)

Completed
Has Results
  • Multiple Myeloma
  • (no location specified)
Apr 29, 2021

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
Has Results
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
May 16, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2021

Lymphoma, Solid Tumor Trial in Rockledge (drug, procedure, other)

Completed
Has Results
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Rockledge, Pennsylvania
    Fox Chase Cancer Center
Feb 2, 2021

Multiple Myeloma Trial (Vorinostat, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • (no location specified)
Apr 7, 2021

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +2 more
  • Bronx, New York
  • +1 more
Feb 1, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Oct 27, 2020